EVERY Company Secures $55 Million in Funding
The EVERY Company has secured $55 million in a Series D funding round to scale production of animal-free egg proteins.
This funding will support the company's expansion into the US market and production of precision-fermented egg proteins.
Investors and Technology
The round was led by McWin Capital Partners, with participation from investors including Main Sequence, Bloom8, and Minerva Foods.
EVERY is proving that biomanufacturing has the potential to transform the food industry
Products and Applications
EVERY's fermentation-based technology offers alternatives to traditional egg proteins, including OvoPro (a substitute for egg whites) and OvoBoost (a neutral protein for food and beverage applications).
- OvoPro: substitute for egg whites
- OvoBoost: neutral protein for various applications
These products can replace conventional eggs in sectors such as baked goods, beverages, and protein supplements.
Author's summary: EVERY Company raises $55 million.
More News
- Democrats pick up seats in both Suffolk and Nassau legislatures
- Suffolk voters [reject/approve] ballot measure extending length of county legislative terms
- Election roundup: Robinson, Carroll, Cantey, Thomas reelected to Lumberton City Council | Robesonian
- Elliott wins Gainesville City Council Ward 2 seat
- Gov. Wes Moore starts Maryland redistricting efforts amid national voter map battle
- The story LI's election numbers tell so far
- McPhaul edges out Kerr for Gainesville school board seat
- Olofsson, Wedgewood lead Avalanche past Lightning 3-2 in rematch of 2022 final
- The Hong Kong Restaurants to Hit According to Ben Sears
- Vintage Blakeman – your man in NYC